Jiangsu Recbio Technology Co., Ltd.
HKEX:2179.HK
8.4 (HKD) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Revenue
| 30.377 | 5.325 | 6.199 | 1.458 | 0 |
| Cost of Revenue
| 8.038 | 0 | 0 | 0 | 0 |
| Gross Profit
| 22.339 | 5.325 | 6.199 | 1.458 | 0 |
| Gross Profit Ratio
| 0.735 | 1 | 1 | 1 | 0 |
| Reseach & Development Expenses
| 487.847 | 716.444 | 472.953 | 130.519 | 63.265 |
| General & Administrative Expenses
| 143.767 | 155.302 | 143.045 | 6.99 | 3.482 |
| Selling & Marketing Expenses
| 8.471 | 8.654 | 3.461 | 0 | 0 |
| SG&A
| 152.238 | 163.956 | 146.506 | 6.99 | 3.482 |
| Other Expenses
| 0 | -5.325 | -6.199 | 9.968 | 8.052 |
| Operating Expenses
| 640.085 | 875.075 | 613.26 | 147.477 | 74.799 |
| Operating Income
| -617.746 | -735.965 | -612.455 | -147.669 | -72.754 |
| Operating Income Ratio
| -20.336 | -138.209 | -98.799 | -101.282 | 0 |
| Total Other Income Expenses Net
| 45.303 | -0.031 | -45.111 | -31.731 | -65.516 |
| Income Before Tax
| -572.443 | -735.996 | -657.566 | -179.4 | -138.27 |
| Income Before Tax Ratio
| -18.845 | -138.215 | -106.076 | -123.045 | 0 |
| Income Tax Expense
| -0.486 | -16.796 | 45.106 | 31.731 | 65.516 |
| Net Income
| -571.957 | -719.2 | -702.672 | -211.131 | -203.786 |
| Net Income Ratio
| -18.829 | -135.061 | -113.352 | -144.809 | 0 |
| EPS
| -1.19 | -1.52 | -1.57 | -0.44 | -0.43 |
| EPS Diluted
| -1.19 | -1.52 | -1.57 | -0.44 | -0.43 |
| EBITDA
| -569.869 | -695.03 | -589.997 | -134.906 | -68.428 |
| EBITDA Ratio
| -18.76 | -130.522 | -95.176 | -92.528 | 0 |